Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Type 1 gastric neuroendocrine tumours (g-NETs) have a high recurrence risk after endoscopic resection, underscoring the need for regular endoscopic follow-up. Our research hints that Traditional Chinese Medicine (TCM) could help lower recurrence rates.
Conference:
Presenting Author: Wang Y
Authors: Wang Y, Cheng Z, Yu F, Chen R, Chen X,
Keywords: type 1 gastric neuroendocrine tumour, Traditional Chinese Medicine, regular follow-up, case report,
Introduction: Combination therapy with PRRT and Capecitabine-Temozolomide (CAPE-TMZ) has benefited patients with FDG avid well-differentiated GEP-NETs.
Conference:
Presenting Author:
Authors: Puranik A, Rangarajan V, Shrikhande S, Ramaswamy A, Ostwal V,
Keywords: PRRT, capecitabine, temozolomide, FDG PET, DOTA PET,
#2700 Pancreatic Neuroendocrine Neoplasms and Liver Metastases: When Size Matters
Introduction: Small non-functioning pNENs are low grade indolent tumors, however distant metastases have also been documented in this subset of patients
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Monteleone M, Rossi R, Altomare M, Prinzi N, Cattaneo L,
Keywords: Pancreatic neuroendocrine neoplasia, Liver metastases,
Introduction: Neuroendocrine tumors (NET) of the pancreas represent a rare entity of primary pancreatic tumors. However, with the continuous progress in modern diagnostics NET`s are increasingly detected and prognostic factors are being reevaluated to establish personalized treatment concepts.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Klein F, Bahra M, Pratschke J, Pavel M, Pape U,
Introduction: The ENETS guidelines classify Gastroenteropancreatic Neuroendocrine Tumours (GEP NETs) according to the histological assessment of tumour mitotic count or Ki67 labelling index (LI) on paraffin-embedded tissue, because proliferation rate has been shown to strongly correlate with prognosis. Since the guidelines were published, Ki67 has been established as the more reproducible measure, and further large case series have been reported.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Cave J
Authors: Richards-Taylor S, Tilley C, Hu J, Pearce N, Armstrong T,